
DeiCell Systems provides regulatory and quality infrastructure designed for life science innovators to pass audits with confidence. They offer tiered QMS models and services including regulatory strategy, SOP development, CAPA, change control, and 21 CFR Part 11 validation readiness. Core tech-enabled features include automated document review, digital QMS deployment, and supplier risk management automation. The company supports ISO 13485-aligned architectures and end-to-end QMS lifecycle planning for biotech, medtech, diagnostics, digital health, and AI-driven therapies. They target early and growth-stage organizations seeking structured, scalable quality systems to reduce risk and accelerate FDA readiness.

DeiCell Systems provides regulatory and quality infrastructure designed for life science innovators to pass audits with confidence. They offer tiered QMS models and services including regulatory strategy, SOP development, CAPA, change control, and 21 CFR Part 11 validation readiness. Core tech-enabled features include automated document review, digital QMS deployment, and supplier risk management automation. The company supports ISO 13485-aligned architectures and end-to-end QMS lifecycle planning for biotech, medtech, diagnostics, digital health, and AI-driven therapies. They target early and growth-stage organizations seeking structured, scalable quality systems to reduce risk and accelerate FDA readiness.